Lung Cancer access options
Lung cancer, also known as lung carcinoma, is characterised by uncontrolled cell growth in tissues of the lung. The two main types are small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC). Non-small cell lung cancer (NSCLC) accounts for approximately 85% of all lung cancers. With an incidence of 1.8 million, lung cancer was the most common cancer worldwide in 2012, contributing 13% of the total number of new cases diagnosed. Treatment and long-term outcomes depend on the type of lung cancer, the stage (degree of spread), and the person’s overall health. Common lung cancer treatments include surgery, chemotherapy, and radiotherapy. NSCLC is sometimes treated with surgery,... Read more » whereas SCLC usually responds better to chemotherapy and radiotherapy.
- Opdivo (Nivolumab)Urothelial Carcinoma, Colorectal Cancer, Head and Neck Cancer, Kidney Cancer, Liver Cancer, Lung Cancer, Lymphoma, Skin Cancer€867.24
- Keytruda (pembrolizumab)Urothelial Carcinoma, Breast Cancer, Colorectal Cancer, Gastric Cancer, Head and Neck Cancer, Kidney Cancer, Lung Cancer, Lymphoma, Skin Cancer€4,225.50
- Afinitor (everolimus)Breast Cancer, Gastric Cancer, Kidney Cancer, Lung Cancer, Intestinal Cancer€4,614.81
Read more about the latest treatments in Lung Cancer